SRM: A Protein Target for Neurodegenerative Disorders and Other Diseases

Target Name: SRM

NCBI ID: G6723

Content of Review Report on SRM Target / Biomarker

SRM

SRM: A Protein Target for Neurodegenerative Disorders and Other Diseases

SRM (SPDSY) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of cell signaling and has been implicated in a number of diseases, including neurodegenerative disorders, diabetes, and cancer.

One of the key functions of SRM is its role as a negative regulator of the TGF-β pathway, which is a well-established pathway that plays a central role in the development and maintenance of tissues and organs. TGF-β signaling is involved in a wide range of processes in the body, including cell growth, differentiation, and survival.

In neurodegenerative disorders, SRM has been implicated in the development and progression of a number of disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by the progressive loss of brain cells and the formation of aggregates of neurotransmitters, such as dopamine and beta-amyloid.

In addition to its role in neurodegenerative disorders, SRM has also been implicated in the development and progression of a number of other diseases, including diabetes and cancer. For example, studies have suggested that SRM may play a role in the development of insulin-dependent diabetes mellitus, a common form of the disease that is characterized by an insatiable appetite and a high risk of complications such as heart attack and stroke.

In addition to its role in disease, SRM has also been the subject of intense research as a potential drug target. Studies have suggested that SRM may be a promising target for a number of different drugs, including neuroprotective agents, anti-inflammatory agents, and immunomodulators.

One of the key advantages of SRM as a drug target is its relatively simple structure. Unlike many other proteins, which have a complex and intricate structure, SRM has a relatively simple and straightforward sequence of amino acids. This makes it easier to identify and modify the protein, which can be a key step in the development of potential drugs.

In addition to its simplicity, another advantage of SRM as a drug target is its widespread expression in various tissues. This makes it a promising target for drugs that can be used to treat a wide range of diseases, rather than being limited to a specific condition.

Overall, SRM is a protein that has the potential to be a drug target due to its role in various diseases and its relatively simple structure. Further research is needed to fully understand the potential of SRM as a drug and to develop safe and effective treatments for the various disorders in which it is involved.

Protein Name: Spermidine Synthase

Functions: Catalyzes the production of spermidine from putrescine and decarboxylated S-adenosylmethionine (dcSAM). Has a strong preference for putrescine as substrate, and has very low activity towards 1,3-diaminopropane. Has extremely low activity towards spermidine

The "SRM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets